Switzerland

Prof. Christian TOSO

Hôpitaux Universitaires de Genève · Genève

Division of Visceral Surgery, Department of Surgery

  • BirthMarch 6, 1973 in Geneva
  • NationalitySwitzerland

Functions and titles

Chief of the Division of Visceral Surgery, Geneva University Hospitals
Full Professor, University of Geneva

Specialty

Liver, pancreatic and transplantation surgery

Hospital titles

Since 2018 - Chief of the Division of Visceral Surgery, HUG
2013–2018 - Senior Surgeon, Division of Visceral Surgery, HUG
2009–2013 - Junior Senior Surgeon, Division of Visceral Surgery, HUG

University titles

Since 2018 - Full Professor, University of Geneva
2013–2018 - Assistant Professor, University of Geneva
2009–2013 - Lecturer (surgery), University of Geneva
2008–2009 - Assistant Clinical Professor, University of Alberta (Canada)

Distinctions and professional societies

2017 - Astellas Award, Swiss Transplantation Meeting
2016 - Riotton Prize, University of Geneva
2015 - Vanguard Award, International Liver Transplantation Society (Chicago)

Languages spoken

French - mother tongue
English - fluent
German - professional

Address

University Hospitals of Geneva
4 Rue Gabrielle-Perret-Gentil
1211 Genève 14
Switzerland

Main publications

  1. Wassmer CH, Gelli M, Wong TCL, … Toso C. The rise of transplant oncology in primary liver cancer and metastatic disease. Hepatology. 2026. doi:10.1097/HEP.0000000000001723.
  2. Bouguerra R, El Hajji S, Wassmer CH, … Toso C. Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy. Hepatology. 2025. doi:10.1097/HEP.0000000000001575.
  3. Moeckli B, Wassmer CH, El Hajji S, … Compagnon P, Toso C. Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: an international retrospective cohort study. Hepatology. 2025;82(5):1122-1137.
  4. Elkrief L, Denecheau-Girard C, Magaz M, … Toso C, … Rautou PE. Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: a multicenter retrospective study. Hepatology. 2025;81(1):152-167.
  5. El Hajji S, Lacotte S, Moeckli B, Cauchy F, Compagnon P, Toso C. Transjugular intrahepatic portosystemic shunt is associated with better waitlist management of liver transplant candidates with hepatocellular carcinoma. Transpl Int. 2024;37:12781.
  6. Moeckli B, Delaune V, Gilbert B, … Lacotte S, Toso C. Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome. JHEP Rep. 2024;6(5):101056.